The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture.
about
Origins of amyloid-βClearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrierDevelopment of indole-3-propionic acid (OXIGON) for Alzheimer's disease.Genetic counselling and genetic screening for Alzheimer's disease and other dementias.Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatmentsStatins for the reduction of risk of Alzheimer's disease.Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning.Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.Translational research on the way to effective therapy for Alzheimer disease.Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.LRP1 shedding in human brain: roles of ADAM10 and ADAM17.Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer diseaseMislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer diseaseCerebral amyloidosis: amyloid subunits, mutants and phenotypes.Molecular pathology and pathogenesis of inclusion-body myositis.The link between cholesterol and Alzheimer's disease.Genes and the environment in neurodegeneration.Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.Genetic aspects of Alzheimer diseasePlasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyAPOE polymorphism, socioeconomic status and cognitive function in mid-life--the Whitehall II longitudinal study.SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways.Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease.Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease.What heterogeneity among centenarians can teach us about genetics, aging, and longevity.Novel PSEN1 mutation in a Bulgarian patient with very early-onset Alzheimer's disease, spastic paraparesis, and extrapyramidal signs.Allele frequencies of +874T --> A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients.Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer's disease.Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse.Precursory signatures of protein folding/unfolding: from time series correlation analysis to atomistic mechanisms.Association of polymorphism in the transcription factor LBP-1c/CP2/LSF gene with Alzheimer's disease and major depression.Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease.Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.A pathogenic p.His169Asn mutation associated with early-onset Alzheimer's diseaseMolecular genetics of Alzheimer’s diseaseHigh-Definition X-Ray Fluorescence: Applications
P2860
Q21266674-22213D54-1937-4039-88B6-039496B55639Q33928434-3061BF79-C960-49BD-A29E-2F57898C501CQ34147767-0DCADDCA-8FBB-43D3-A5F7-06973EF1A749Q34174215-65B0D8AC-40A7-41FD-B69C-03692F4F51D1Q34310402-86FB540D-8548-4F57-9B0E-E9A77BEA9BBCQ34424251-31E392CB-0D66-460B-8E33-C1B593FD9D39Q34505808-2D0C391C-F9A9-4A93-A5E0-97CC7F856263Q34680488-B804931E-DE80-4679-8324-594B7D998856Q34684381-8111DDA9-2437-401A-AF43-01BD892426DDQ34824832-D946B02D-9F93-45F4-939A-166BAE16F6C8Q34928142-4025C54C-B2D3-4EEF-A3E9-41436F544405Q34976135-09DC6DDB-645F-44E6-BE82-DB8E7A4156C7Q35020981-6E1C9D94-EC3C-460B-8492-FA6739AACC8EQ35157679-59BA4D15-F657-43B0-930B-CC3FA949CB67Q36136387-8459EE3D-56C8-4E49-89DF-A480DD2AB892Q36231849-7BA23C13-70B5-42C0-A013-0B9F3B591C6FQ36255194-C9FD47D0-523C-4AFD-89F4-664ADD3773E1Q36617960-0F326EA0-4521-4B39-98A4-D4ECD295DD50Q36983588-C8697E14-85C5-45E7-8DED-F381F7058E59Q37139063-6D6CB095-455F-40E5-897A-13254B9D3A20Q37163332-6BDFDFB9-E247-4FFB-83BD-F824886CEFE3Q37338819-73C35215-2B64-4349-8234-324D63D2726CQ37340286-B4CDF747-ACC0-485D-AD63-85FE83F3D92EQ37785102-8361833E-7B42-42C8-B3E2-70743A1C048DQ42225006-D0B69AC5-7422-4E41-B7FE-A1B27FF0BC03Q43915212-70AE0BDA-2DA7-41D5-ACC7-3239037E9A11Q43927932-94E3A98E-748E-4569-A2DB-5AE78D2FDC45Q44684179-7EADEC89-004B-4FAF-A220-05199CC91581Q47803101-7D86C742-54B9-4305-B863-8C258D137517Q48636699-DBDE1BD3-F3B3-43D7-BA2E-DB38D9BF384AQ51082531-EA685DE8-27AE-45E5-909E-A8CA3FF24BF8Q53277934-A9AB3147-23B7-4A68-8C19-A6C7560C45EEQ53279548-F118159A-1B07-45FC-8C8B-508727A24FDAQ53357994-AB76CFEF-18B8-4F6E-9276-F940A4A49C9BQ57173917-BC8B8B98-85CE-4CCF-A81D-CDEAF5202108Q58007043-901C86AC-E233-49C8-86F8-A27DFEABDBF1Q58644906-CE9DD4C1-4558-454D-ADA0-17BDF93BE99E
P2860
The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@en
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@nl
type
label
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@en
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@nl
prefLabel
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@en
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@nl
P356
P1433
P1476
The molecular and genetic basi ...... : the 2000 Wartenberg lecture.
@en
P2093
Rosenberg RN
P304
P356
10.1212/WNL.54.11.2045
P407
P577
2000-06-01T00:00:00Z